After building a $1.7 billion pharmacy empire over 48 years, South African tycoon begins final handover
Ivan Saltzman, the founder who transformed Dis-Chem from a single pharmacy into a prominent healthcare retailer across southern Africa, is preparing to step down as chairman.
This departure signifies the concluding stage of a carefully planned leadership transition and succession process involving both the family and the business.
Dis-Chem, currently valued at approximately $1.7 billion, manages hundreds of retail outlets throughout South Africa, Namibia, and Botswana.
The company’s succession plan is under close scrutiny, given the common challenges founder-led African enterprises encounter regarding continuity and corporate governance.
Saltzman, who established Dis-Chem alongside his wife, Lynette, in 1978, will retire as chairman of the Johannesburg-listed healthcare retailer on June 30. This completes a meticulously managed leadership transition that commenced almost two years prior when he relinquished his role as chief executive.
His exit will signify the ultimate stage of a succession plan that has also redefined the founding family’s leadership and ownership framework. This transition is expected to challenge Dis-Chem’s succession strategy and the Saltzman family’s capacity to effectively transfer both management responsibilities and wealth to the subsequent generation.
The enterprise, which started with funds borrowed from Saltzman’s mother to acquire the pharmacy he managed, has expanded into a healthcare retail conglomerate now valued at approximately $1.7 billion.
Currently, Dis-Chem manages hundreds of outlets throughout South Africa, Namibia, and Botswana, providing prescription medications, health and beauty items, wellness programs, in-store medical clinics, and health insurance.
This anticipated leadership transfer occurs as founder-led businesses across Africa increasingly face the complexities of succession planning. Investors are keen to evaluate if companies established by entrepreneurial founders can maintain their growth trajectory once those founders depart.
Saltzman’s departure has been meticulously orchestrated, avoiding any suddenness. In 2023, he delegated daily leadership responsibilities to long-serving executive Rui Morais, who has since guided the company while Saltzman continued as chairman to supervise the transition.
Succession has presented difficulties for various South African retail conglomerates, rendering Dis-Chem’s leadership transfer a particularly observed event by investors.
The transition process has encompassed more than just boardroom changes, also impacting the Saltzman family’s ownership and leadership framework.
Co-founder Lynette Saltzman resigned as an executive director in 2022, choosing to concentrate on the group’s beauty division.
The couple’s three sons have also assumed changing responsibilities: Saul stepped down as an executive director in February 2025, while Mark and Dan gained central importance in the family’s succession strategy after each acquiring a 12.5% stake in Dis-Chem following a June 2025 restructuring.
This reorganization decreased the family’s investment vehicle, Ivlyn, from a 29% ownership to approximately 4%, yet the Saltzmans remain among the retailer’s most significant shareholders. Despite Mark and Dan each selling shares valued at around R321 million earlier this year, both still possess equity stakes worth billions of rand.
This meticulously managed succession mirrors a wider pattern observed in family-controlled enterprises, where founders are progressively transferring ownership and governance duties to the subsequent generation, all while retaining long-term strategic sway over the companies they established.
Dis-Chem embarks on its post-founder period with ambitious growth strategies. Under Morais’s leadership, the retailer is investing in its Health Hub model, which combines pharmacies with clinics, diagnostic facilities, telemedicine, and health insurance, aiming to solidify its standing in South Africa’s changing healthcare sector.
The company is simultaneously contending with a difficult retail landscape characterized by reduced consumer expenditure and escalating operational expenses, rendering its leadership transition especially crucial.
For investors, the primary concern is no longer Saltzman’s ability to establish a successful company—a feat he accomplished over four decades. Instead, the current focus is on whether the systems, governance structures, and leadership he instills can maintain Dis-Chem’s expansion long after its founder’s departure.
As one of South Africa’s most notable founder successions progresses, Dis-Chem’s forthcoming chapter is poised to serve as a case study on how African family enterprises manage the shift from an entrepreneurial vision to enduring institutional stability.
